{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:42:53Z","timestamp":1795070573048,"version":"4.10.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:00:00Z","timestamp":1613347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SIRT1 prevents retinal ganglion cell (RGC) loss in models of optic neuropathy following pharmacologic activation or genetic overexpression. The exact mechanism of loss is not known, prior evidence suggests this is through oxidative stress to either neighboring cells or RGC specifically. We investigated the neuroprotective potential of RGC-selective SIRT1 gene therapy in the optic nerve crush (ONC) model. We hypothesized that AAV-mediated overexpression of SIRT1 in RGCs reduces RGC loss, thereby preserving visual function. Cohorts of C57Bl\/6J mice received intravitreal injection of experimental or control AAVs using either a ganglion cell promoter or a constitutive promoter and ONC was performed. Visual function was examined by optokinetic response (OKR) for 7 days following ONC. Retina and optic nerves were harvested to investigate RGC survival by immunolabeling. The AAV7m8-SNCG.SIRT1 vector showed 44% transduction efficiency for RGCs compared with 25% (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) by AAV2-CAG.SIRT1, and AAV7m8-SNCG.SIRT1 drives expression selectively in RGCs in vivo. Animals modeling ONC demonstrated reduced visual acuity compared to controls. Intravitreal delivery of AAV7m8-SNCG.SIRT1 mediated significant preservation of the OKR and RGC survival compared to AAV7m8-SNCG.eGFP controls, an effect not seen with the AAV2 vector. RGC-selective expression of SIRT1 offers a targeted therapy for an animal model with significant ganglion cell loss. Over-expression of SIRT1 through AAV-mediated gene transduction suggests a RGC selective component of neuro-protection using the ONC model. This study expands our understanding of SIRT1 mediated neuroprotection in the context of compressive or traumatic optic neuropathy, making it a strong therapeutic candidate for testing in all optic neuropathies.<\/jats:p>","DOI":"10.1038\/s41434-021-00219-z","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T14:54:00Z","timestamp":1613573640000},"page":"256-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Rescue of retinal ganglion cells in optic nerve injury using cell-selective AAV mediated delivery of SIRT1"],"prefix":"10.1038","volume":"28","author":[{"given":"Ahmara G.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin S.","family":"McDougald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reas S.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu T.","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-7261","authenticated-orcid":false,"given":"Kimberly E.","family":"Dine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4409-4283","authenticated-orcid":false,"given":"Puya","family":"Aravand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3378-8263","authenticated-orcid":false,"given":"Jean","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Ramana Murthy","family":"Chavali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"219_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13004\/kjnt.2018.14.1.1","volume":"14","author":"SY Jang","year":"2018","unstructured":"Jang SY. Traumatic optic neuropathy. Korean J Neurotrauma. 2018;14:1\u20135.","journal-title":"Korean J Neurotrauma."},{"key":"219_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-0034-1393734","volume":"8","author":"AM Kumaran","year":"2015","unstructured":"Kumaran AM, Sundar G, Chye LT. Traumatic optic neuropathy: a review. Craniomaxillofac Trauma Reconstr. 2015;8:31\u201341.","journal-title":"Craniomaxillofac Trauma Reconstr."},{"key":"219_CR3","doi-asserted-by":"publisher","unstructured":"Tang Z, Zhang S, Lee C, Kumar A, Arjunan P, Li Y, et al. An optic nerve crush injury murine model to study retinal ganglion cell survival. J Vis Exp. 2011:2685. https:\/\/doi.org\/10.3791\/2685.","DOI":"10.3791\/2685"},{"key":"219_CR4","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1167\/iovs.13-12157","volume":"54","author":"L Zuo","year":"2013","unstructured":"Zuo L, Khan RS, Lee V, Dine K, Wu W, Shindler KS. SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci. 2013;54:5097\u2013102.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"219_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","volume":"30","author":"KS Shindler","year":"2010","unstructured":"Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC, Rostami A. Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol. 2010;30:328\u201339.","journal-title":"J Neuroophthalmol."},{"key":"219_CR6","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1167\/iovs.07-0131","volume":"48","author":"KS Shindler","year":"2007","unstructured":"Shindler KS, Ventura E, Rex TS, Elliott P, Rostami A. SIRT1 activation confers neuroprotection in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2007;48:3602\u20139.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"219_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/WNO.0000000000000760","volume":"39","author":"RS Khan","year":"2019","unstructured":"Khan RS, Dine K, Wessel H, Brown L, Shindler KS. Effects of varying intranasal treatment regimens in ST266-mediated retinal ganglion cell neuroprotection. J Neuroophthalmol. 2019;39:191\u20139.","journal-title":"J Neuroophthalmol."},{"key":"219_CR8","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1167\/iovs.17-22972","volume":"59","author":"DS McDougald","year":"2018","unstructured":"McDougald DS, Dine KE, Zezulin AU, Bennett J, Shindler KS. SIRT1 and NRF2 gene transfer mediate distinct neuroprotective effects upon retinal ganglion cell survival and function in experimental optic neuritis. Invest Ophthalmol Vis Sci. 2018;59:1212\u201320.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"219_CR9","first-page":"523","volume":"90","author":"L Chan","year":"2017","unstructured":"Chan L, Mahajan VB, Tsang SH. Genome surgery and gene therapy in retinal disorders. Yale J Biol Med. 2017;90:523\u201332.","journal-title":"Yale J Biol Med."},{"key":"219_CR10","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/ICU.0000000000000473","volume":"29","author":"A DeBusk","year":"2018","unstructured":"DeBusk A, Moster ML. Gene therapy in optic nerve disease. Curr Opin Ophthalmol. 2018;29:234\u20138.","journal-title":"Curr Opin Ophthalmol."},{"key":"219_CR11","doi-asserted-by":"publisher","first-page":"e0134995","DOI":"10.1371\/journal.pone.0134995","volume":"10","author":"W Yang","year":"2015","unstructured":"Yang W, Liu Y, Slovik KJ, Wu JC, Duncan SA, Rader DJ, et al. Generation of iPSCs as a pooled culture using magnetic activated cell sorting of newly reprogrammed cells. PLoS ONE. 2015;10:e0134995.","journal-title":"PLoS ONE."},{"key":"219_CR12","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/stem.2513","volume":"35","author":"P Teotia","year":"2017","unstructured":"Teotia P, Chopra DA, Dravid SM, Van Hook MJ, Qiu F, Morrison J, et al. Generation of functional human retinal ganglion cells with target specificity from pluripotent stem cells by chemically defined recapitulation of developmental mechanism. Stem Cells. 2017;35:572\u201385.","journal-title":"Stem Cells."},{"key":"219_CR13","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ymthe.2017.07.011","volume":"25","author":"A Chaffiol","year":"2017","unstructured":"Chaffiol A, Caplette R, Jaillard C, Brazhnikova E, Desrosiers M, Dubus E, et al. A new promoter allows optogenetic vision restoration with enhanced sensitivity in Macaque retina. Mol Ther. 2017;25:2546\u201360.","journal-title":"Mol Ther."},{"key":"219_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"F Costello","year":"2006","unstructured":"Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol. 2006;59:963\u20139.","journal-title":"Ann Neurol."},{"key":"219_CR15","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.1167\/iovs.04-0541","volume":"45","author":"GT Prusky","year":"2004","unstructured":"Prusky GT, Alam NM, Beekman S, Douglas RM. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci. 2004;45:4611\u20136.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"219_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fneur.2011.00050","volume":"2","author":"TA Quinn","year":"2011","unstructured":"Quinn TA, Dutt M, Shindler KS. Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol. 2011;2:50.","journal-title":"Front Neurol."},{"key":"219_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3389\/fneur.2012.00084","volume":"3","author":"Z Fonseca-Kelly","year":"2012","unstructured":"Fonseca-Kelly Z, Nassrallah M, Uribe J, Khan RS, Dine K, Dutt M, et al. Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Front Neurol. 2012;3:84.","journal-title":"Front Neurol."},{"key":"219_CR18","doi-asserted-by":"publisher","first-page":"26559","DOI":"10.1038\/srep26559","volume":"6","author":"K Zarei","year":"2016","unstructured":"Zarei K, Scheetz TE, Christopher M, Miller K, Hedberg-Buenz A, Tandon A, et al. Automated axon counting in rodent optic nerve sections with AxonJ. Sci Rep. 2016;6:26559.","journal-title":"Sci Rep."},{"key":"219_CR19","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1038\/s41598-020-68811-8","volume":"10","author":"VRM Chavali","year":"2020","unstructured":"Chavali VRM, Haider N, Rathi S, Alapati T, He J, Gill K, et al. Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells. Sci Rep. 2020;10:11828.","journal-title":"Sci Rep."},{"key":"219_CR20","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/S0042-6989(98)00308-3","volume":"39","author":"L Dudus","year":"1999","unstructured":"Dudus L, Anand V, Acland GM, Chen SJ, Wilson JM, Fisher KJ, et al. Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. Vision Res. 1999;39:2545\u201353.","journal-title":"Vision Res."},{"key":"219_CR21","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1167\/iovs.18-24096","volume":"59","author":"GA Grinblat","year":"2018","unstructured":"Grinblat GA, Khan RS, Dine K, Wessel H, Brown L, Shindler KS. RGC neuroprotection following optic nerve trauma mediated by intranasal delivery of amnion cell secretome. Investig Ophthalmol Vis Sci. 2018;59:2470\u20137.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"219_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","volume":"388","author":"J Bennett","year":"2016","unstructured":"Bennett J, Wellman J, Marshall KA, McCague S, Ashtari M, DiStefano-Pappas J, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016;388:661\u201372.","journal-title":"Lancet."},{"key":"219_CR23","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","volume":"358","author":"AM Maguire","year":"2008","unstructured":"Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr., Mingozzi F, Bennicelli J, et al. Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis. N Engl J Med. 2008;358:2240\u20138.","journal-title":"N Engl J Med."},{"key":"219_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep41768","volume":"7","author":"RS Khan","year":"2017","unstructured":"Khan RS, Dine K, Bauman B, Lorentsen M, Lin L, Brown H, et al. Intranasal delivery of a novel amnion cell secretome prevents neuronal damage and preserves function in a mouse multiple sclerosis model. Sci Rep. 2017;7:41768.","journal-title":"Sci Rep."},{"key":"219_CR25","doi-asserted-by":"publisher","first-page":"3187594","DOI":"10.1155\/2017\/3187594","volume":"2017","author":"S Balaiya","year":"2017","unstructured":"Balaiya S, Abu-Amero KK, Kondkar AA, Chalam KV. Sirtuins expression and their role in retinal diseases. Oxid Med Cell Longev. 2017;2017:3187594.","journal-title":"Oxid Med Cell Longev."},{"key":"219_CR26","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1167\/iovs.11-9259","volume":"53","author":"S Balaiya","year":"2012","unstructured":"Balaiya S, Ferguson LR, Chalam KV. Evaluation of sirtuin role in neuroprotection of retinal ganglion cells in hypoxia. Invest Ophthalmol Vis Sci. 2012;53:4315\u201322.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"219_CR27","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1074\/jbc.M501485200","volume":"280","author":"S Nemoto","year":"2005","unstructured":"Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem. 2005;280:16456\u201360.","journal-title":"J Biol Chem."},{"key":"219_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 2001;107:137\u201348.","journal-title":"Cell."},{"key":"219_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fncel.2012.00063","volume":"6","author":"RS Khan","year":"2012","unstructured":"Khan RS, Fonseca-Kelly Z, Callinan C, Zuo L, Sachdeva MM, Shindler KS. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front Cell Neurosci. 2012;6:63.","journal-title":"Front Cell Neurosci."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-021-00219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-021-00219-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-021-00219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:41Z","timestamp":1684617281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-021-00219-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1038\/s41434-021-00219-z","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,15]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JB is a founder of Gensight Therapeutics and Limelight Bio and a scientific founder of Spark Therapeutics. JB receives a grant from Limelight Bio, is on the SAB for Akouos, and holds intellectual property relevant to this study. AGR, DSM, and KSS hold intellectual property relevant to this study. The other authors whose names are listed immediately below (RSK, TTD, KED, PA, VRMC) certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}